Updated from 6:56 a.m. EDTEli Lilly ( LLY) reported first-quarter net income rose 24% to $1.31 billion, or $1.20 a share, topping analysts' estimates of 99 cents a share as total revenue rose 5% to $5.05 billion. In the year-earlier first quarter, the health care company reported earnings of $1.06 billion, or 97 cents a share, on sales of $4.81 billion. The company reconfirmed its 2009 financial guidance, including earnings guidance of $4 to $4.25 a share. Analysts expect earnings of $4.14 a share. The drugmaker said its first-quarter profits rose on a boost in sales of the antidepressant Cymbalta and the insulin Humalog as costs fell. Higher prices for several drugs also helped revenue.